All tenders
75N98026P01085
MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
Department of Health and Human Services · MD, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N98026P01085
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
- Source
- usaspending
- Source ID
- CONT_AWD_75N98026P01085_7529_-NONE-_-NONE-
Details
- Location
- MD, United States
Description
MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH Awarded to: OLINK PROTEOMICS INC Sub-agency: National Institutes of Health Contract type: PURCHASE ORDER
Dates
- Publication
- 2026/07/21 12:00:00 AM UTC
- Closing date
- 2027/07/20 12:00:00 AM UTC
Estimated value
$47K USD
Classification
Normalized category
Other